# Ayurvedic — company-by-company sector analysis

> Ayurvedic: Jeena Sikho Lifecare Ltd owns the largest revenue base; Zota Health Care Ltd has the fastest current growth.

Sector Alpha — machine-written from the numbers. Data as of 2026-08-20. Not investment advice.

## Bottom line

Ayurvedic has underperformed NIFTY 500 by 34.3% over 52 weeks and 15.6% over 13 weeks. 0 of 2 covered companies beat NIFTY on Mansfield relative strength, while 1 of 2 beat the sector itself. Jeena Sikho Lifecare Ltd leads with revenue of ₹852 crore, based on 2 of 2 comparable companies through Jun 2026.

## Sector relative strength

Ayurvedic has underperformed NIFTY 500 by 34.3% over the last 52 weeks. Over 13 weeks the gap is a shortfall of 15.6%. 0 of 2 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Jeena Sikho Lifecare Ltd is the strongest against the sector itself at +1.6%.

13-week sector return versus NIFTY 500: -16%
52-week sector return versus NIFTY 500: -34%
Stocks leading NIFTY: 0/2
Stocks leading sector: 1/2

Central tension: The central tension: the companies with the most scale are not necessarily the companies creating the most change.

Companies: 2
Combined market value: ₹10.4K Cr

## 4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

1. Jeena Sikho Lifecare Ltd (JSLL): 62/100 — Mixed-positive evidence; evidence 84%
   - Growth & earnings 28.0/35 | Capital efficiency 20.0/25 | Valuation 5.0/20 | Relative strength 8.9/20
   - Price stage: ASLEEP — Neither ahead of the benchmark nor yet turning up against it.
   - Led NIFTY 500 by 5%+ over the prior 13 weeks in 0 of 10 weeks with a reading, within the last 12
   - Exact sum: 28 + 20 + 5 + 8.9 = 61.9
   - Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
2. Zota Health Care Ltd (ZOTA): 34/100 — Adverse evidence; evidence 65%
   - Growth & earnings 20.5/35 | Capital efficiency 0.0/25 | Valuation 10.0/20 | Relative strength 3.2/20
   - Price stage: ASLEEP — Neither ahead of the benchmark nor yet turning up against it.
   - Led NIFTY 500 by 5%+ over the prior 13 weeks in 2 of 10 weeks with a reading, within the last 12
   - Exact sum: 20.5 + 0 + 10 + 3.2 = 33.7
   - Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

## Market action

Jeena Sikho Lifecare Ltd has the strongest one-year price move in Ayurvedic at -4.8%. Zota Health Care Ltd leads on Mansfield relative strength against NIFTY at -18.2%. 0 of 2 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-08-14.

### Strongest one-year price performers
1. Jeena Sikho Lifecare Ltd (JSLL): -4.8%
2. Zota Health Care Ltd (ZOTA): -5.9%

### Strongest relative strength versus NIFTY 500
1. Zota Health Care Ltd (ZOTA): -18%
2. Jeena Sikho Lifecare Ltd (JSLL): -24%

## Revenue Scale & Growth Durability

What the numbers say: Jeena Sikho Lifecare Ltd is the scale leader at ₹852 crore, 39.9% ahead of Zota Health Care Ltd. Zota Health Care Ltd's growth is 79.1% from a ₹609 crore base, with 20 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

Investor read: Jeena Sikho Lifecare Ltd is the scale benchmark; Zota Health Care Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Jeena Sikho Lifecare Ltd's growth falls below Zota Health Care Ltd's for two consecutive comparable reports while operating margin also compresses.

Evidence: Jeena Sikho Lifecare Ltd · ₹852 crore | 39.9% versus #2 · Zota Health Care Ltd | 8/8 recent comparable periods | 2/2 companies · 37 observations

Definition: Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.

### Revenue — largest
1. Jeena Sikho Lifecare Ltd (JSLL): ₹852 Cr
2. Zota Health Care Ltd (ZOTA): ₹609 Cr

### Revenue growth — fastest growers
1. Zota Health Care Ltd (ZOTA): 79%
2. Jeena Sikho Lifecare Ltd (JSLL): 57%

### 20-quarter Revenue history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 ₹43 Cr | Sep 2022 ₹43 Cr | Dec 2022 ₹59 Cr | Mar 2023 ₹58 Cr | Jun 2023 ₹79 Cr | Sep 2023 ₹79 Cr | Dec 2023 ₹84 Cr | Mar 2024 ₹84 Cr | Jun 2024 ₹107 Cr | Sep 2024 ₹114 Cr | Dec 2024 ₹116 Cr | Mar 2025 ₹139 Cr | Jun 2025 ₹174 Cr | Sep 2025 ₹190 Cr | Dec 2025 ₹222 Cr | Mar 2026 ₹216 Cr | Jun 2026 ₹224 Cr
- ZOTA: Sep 2021 ₹35 Cr | Dec 2021 ₹31 Cr | Mar 2022 ₹31 Cr | Jun 2022 ₹29 Cr | Sep 2022 ₹39 Cr | Dec 2022 ₹35 Cr | Mar 2023 ₹37 Cr | Jun 2023 ₹39 Cr | Sep 2023 ₹45 Cr | Dec 2023 ₹47 Cr | Mar 2024 ₹50 Cr | Jun 2024 ₹56 Cr | Sep 2024 ₹67 Cr | Dec 2024 ₹72 Cr | Mar 2025 ₹97 Cr | Jun 2025 ₹104 Cr | Sep 2025 ₹129 Cr | Dec 2025 ₹143 Cr | Mar 2026 ₹163 Cr | Jun 2026 ₹174 Cr

### 20-quarter Revenue growth history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 — | Sep 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 84% | Sep 2023 84% | Dec 2023 42% | Mar 2024 45% | Jun 2024 35% | Sep 2024 44% | Dec 2024 38% | Mar 2025 65% | Jun 2025 63% | Sep 2025 67% | Dec 2025 91% | Mar 2026 55% | Jun 2026 29%
- ZOTA: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 -12% | Sep 2022 11% | Dec 2022 13% | Mar 2023 19% | Jun 2023 34% | Sep 2023 15% | Dec 2023 34% | Mar 2024 35% | Jun 2024 44% | Sep 2024 49% | Dec 2024 53% | Mar 2025 94% | Jun 2025 86% | Sep 2025 93% | Dec 2025 99% | Mar 2026 68% | Jun 2026 67%

## Operating Economics & Margin Trend

What the numbers say: Jeena Sikho Lifecare Ltd leads both opm at 41% and margin change at -4 percentage points.

Investor read: Jeena Sikho Lifecare Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Evidence: Jeena Sikho Lifecare Ltd · 41% | 685.7% versus #2 · Zota Health Care Ltd | 6/8 recent comparable periods | 2/2 companies · 39 observations

Definition: Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.

### OPM — highest
1. Jeena Sikho Lifecare Ltd (JSLL): 41%
2. Zota Health Care Ltd (ZOTA): -7.0%

### Margin change — fastest expanders
1. Jeena Sikho Lifecare Ltd (JSLL): −4.0 pp
2. Zota Health Care Ltd (ZOTA): −10.8 pp

### 20-quarter OPM history
- JSLL: Sep 2021 13% | Dec 2021 — | Mar 2022 12% | Jun 2022 17% | Sep 2022 18% | Dec 2022 24% | Mar 2023 25% | Jun 2023 27% | Sep 2023 27% | Dec 2023 27% | Mar 2024 27% | Jun 2024 26% | Sep 2024 35% | Dec 2024 26% | Mar 2025 33% | Jun 2025 45% | Sep 2025 48% | Dec 2025 45% | Mar 2026 36% | Jun 2026 41%
- ZOTA: Sep 2021 14% | Dec 2021 16% | Mar 2022 0.2% | Jun 2022 5.0% | Sep 2022 12% | Dec 2022 0.0% | Mar 2023 2.8% | Jun 2023 3.3% | Sep 2023 10% | Dec 2023 7.0% | Mar 2024 -3.0% | Jun 2024 -2.2% | Sep 2024 -1.3% | Dec 2024 -8.0% | Mar 2025 2.5% | Jun 2025 3.8% | Sep 2025 4.9% | Dec 2025 -0.3% | Mar 2026 5.0% | Jun 2026 -7.0%

### 20-quarter Margin change history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 +0.1 pp | Jun 2022 — | Sep 2022 +5.8 pp | Dec 2022 — | Mar 2023 +13.1 pp | Jun 2023 +10.0 pp | Sep 2023 +8.5 pp | Dec 2023 +3.7 pp | Mar 2024 +2.3 pp | Jun 2024 −0.7 pp | Sep 2024 +8.0 pp | Dec 2024 −1.4 pp | Mar 2025 +5.6 pp | Jun 2025 +18.7 pp | Sep 2025 +13.0 pp | Dec 2025 +19.0 pp | Mar 2026 +3.0 pp | Jun 2026 −4.0 pp
- ZOTA: Sep 2021 +10.7 pp | Dec 2021 +20.0 pp | Mar 2022 +0.9 pp | Jun 2022 −9.7 pp | Sep 2022 −1.3 pp | Dec 2022 −16.1 pp | Mar 2023 +2.6 pp | Jun 2023 −1.7 pp | Sep 2023 −2.4 pp | Dec 2023 +7.0 pp | Mar 2024 −5.8 pp | Jun 2024 −5.5 pp | Sep 2024 −11.3 pp | Dec 2024 −15.0 pp | Mar 2025 +5.5 pp | Jun 2025 +6.0 pp | Sep 2025 +6.2 pp | Dec 2025 +7.7 pp | Mar 2026 +2.5 pp | Jun 2026 −10.8 pp

## Profit Scale & Acceleration

What the numbers say: Jeena Sikho Lifecare Ltd leads with ₹237 crore of TTM profit, 327.9% above Zota Health Care Ltd. Jeena Sikho Lifecare Ltd shows ≥100% on the scoring scale (104.3% uncapped) growth from a ₹237 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

Investor read: Jeena Sikho Lifecare Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Evidence: Jeena Sikho Lifecare Ltd · ₹237 crore | 327.9% versus #2 · Zota Health Care Ltd | 7/8 recent comparable periods | 2/2 companies · 37 observations

Definition: Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.

### Net profit — largest
1. Jeena Sikho Lifecare Ltd (JSLL): ₹237 Cr
2. Zota Health Care Ltd (ZOTA): ₹-104 Cr

### Profit growth — fastest growers
1. Jeena Sikho Lifecare Ltd (JSLL): 100%

### 20-quarter Net profit history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 ₹6 Cr | Sep 2022 ₹6 Cr | Dec 2022 ₹11 Cr | Mar 2023 ₹11 Cr | Jun 2023 ₹16 Cr | Sep 2023 ₹16 Cr | Dec 2023 ₹19 Cr | Mar 2024 ₹19 Cr | Jun 2024 ₹23 Cr | Sep 2024 ₹27 Cr | Dec 2024 ₹13 Cr | Mar 2025 ₹25 Cr | Jun 2025 ₹51 Cr | Sep 2025 ₹59 Cr | Dec 2025 ₹67 Cr | Mar 2026 ₹45 Cr | Jun 2026 ₹66 Cr
- ZOTA: Sep 2021 ₹3 Cr | Dec 2021 ₹3 Cr | Mar 2022 ₹-1 Cr | Jun 2022 ₹-1 Cr | Sep 2022 ₹1 Cr | Dec 2022 ₹-3 Cr | Mar 2023 ₹-3 Cr | Jun 2023 ₹-3 Cr | Sep 2023 ₹-2 Cr | Dec 2023 ₹-3 Cr | Mar 2024 ₹-7 Cr | Jun 2024 ₹-13 Cr | Sep 2024 ₹-12 Cr | Dec 2024 ₹-19 Cr | Mar 2025 ₹-13 Cr | Jun 2025 ₹-14 Cr | Sep 2025 ₹-16 Cr | Dec 2025 ₹-30 Cr | Mar 2026 ₹-14 Cr | Jun 2026 ₹-44 Cr

### 20-quarter Profit growth history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 — | Sep 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 167% | Sep 2023 167% | Dec 2023 73% | Mar 2024 73% | Jun 2024 44% | Sep 2024 69% | Dec 2024 -32% | Mar 2025 32% | Jun 2025 122% | Sep 2025 119% | Dec 2025 415% | Mar 2026 80% | Jun 2026 29%
- ZOTA: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 -133% | Sep 2022 -67% | Dec 2022 -200% | Mar 2023 — | Jun 2023 — | Sep 2023 -300% | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 — | Jun 2025 — | Sep 2025 — | Dec 2025 — | Mar 2026 — | Jun 2026 —

## Return On Capital Employed

What the numbers say: Jeena Sikho Lifecare Ltd leads ROCE at 64.1%, 72.6 percentage points above Zota Health Care Ltd. Jeena Sikho Lifecare Ltd has the strongest latest improvement at +11.7 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

Investor read: Jeena Sikho Lifecare Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

Evidence: Jeena Sikho Lifecare Ltd · 64.1% | 856.8% versus #2 · Zota Health Care Ltd | 6/8 recent comparable periods | 2/2 companies · 29 observations

Definition: ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.

### ROCE — highest
1. Jeena Sikho Lifecare Ltd (JSLL): 64%
2. Zota Health Care Ltd (ZOTA): -8.5%

### ROCE change — fastest improvers
1. Jeena Sikho Lifecare Ltd (JSLL): +11.7 pp
2. Zota Health Care Ltd (ZOTA): +7.0 pp

### 20-quarter ROCE history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 6.9% | Sep 2022 14% | Dec 2022 23% | Mar 2023 34% | Jun 2023 37% | Sep 2023 46% | Dec 2023 41% | Mar 2024 46% | Jun 2024 — | Sep 2024 44% | Dec 2024 — | Mar 2025 41% | Jun 2025 71% | Sep 2025 48% | Dec 2025 85% | Mar 2026 53% | Jun 2026 —
- ZOTA: Sep 2021 6.4% | Dec 2021 — | Mar 2022 11% | Jun 2022 — | Sep 2022 3.6% | Dec 2022 — | Mar 2023 -3.3% | Jun 2023 — | Sep 2023 -5.1% | Dec 2023 -4.4% | Mar 2024 -8.1% | Jun 2024 -14% | Sep 2024 -12% | Dec 2024 -22% | Mar 2025 -14% | Jun 2025 -19% | Sep 2025 -11% | Dec 2025 -15% | Mar 2026 -7.2% | Jun 2026 —

### 20-quarter ROCE change history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 — | Sep 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 +29.7 pp | Sep 2023 +31.6 pp | Dec 2023 +18.6 pp | Mar 2024 +11.5 pp | Jun 2024 — | Sep 2024 −1.1 pp | Dec 2024 — | Mar 2025 −4.4 pp | Jun 2025 — | Sep 2025 +3.2 pp | Dec 2025 — | Mar 2026 +11.7 pp | Jun 2026 —
- ZOTA: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 — | Sep 2022 −2.8 pp | Dec 2022 — | Mar 2023 −14.2 pp | Jun 2023 — | Sep 2023 −8.7 pp | Dec 2023 — | Mar 2024 −4.8 pp | Jun 2024 — | Sep 2024 −7.0 pp | Dec 2024 −17.1 pp | Mar 2025 −6.1 pp | Jun 2025 −5.1 pp | Sep 2025 +1.0 pp | Dec 2025 +6.8 pp | Mar 2026 +7.0 pp | Jun 2026 —

## Valuation Against Growth & Quality

What the numbers say: Jeena Sikho Lifecare Ltd has the lowest comparable PEG at 4.58×. Only 1 of 2 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

Evidence: Jeena Sikho Lifecare Ltd · 4.58× | Not enough peers | 0/8 recent comparable periods | 1/2 companies · 3 observations

Definition: PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.

### PEG — lowest PEG
1. Jeena Sikho Lifecare Ltd (JSLL): 4.6

### P/E — lowest P/E
1. Jeena Sikho Lifecare Ltd (JSLL): 27.4

### 20-quarter PEG history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 — | Sep 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 1.7 | Sep 2024 2.4 | Dec 2024 — | Mar 2025 4.6 | Jun 2025 — | Sep 2025 — | Dec 2025 — | Mar 2026 — | Jun 2026 —

### 20-quarter P/E history
- JSLL: Sep 2021 — | Dec 2021 — | Mar 2022 — | Jun 2022 34.1 | Sep 2022 14.3 | Dec 2022 18.1 | Mar 2023 22.4 | Jun 2023 19.4 | Sep 2023 38.9 | Dec 2023 44.1 | Mar 2024 62.8 | Jun 2024 80.2 | Sep 2024 114.3 | Dec 2024 159.6 | Mar 2025 162.9 | Jun 2025 158.3 | Sep 2025 299.6 | Dec 2025 260.0 | Mar 2026 34.1 | Jun 2026 33.7
- ZOTA: Sep 2021 499.5 | Dec 2021 203.8 | Mar 2022 84.7 | Jun 2022 66.9 | Sep 2022 152.1 | Dec 2022 316.3 | Mar 2023 327.7 | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 — | Jun 2025 — | Sep 2025 — | Dec 2025 — | Mar 2026 — | Jun 2026 —


## What can make this comparison misleading?
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- Thin comparisons: Valuation have fewer than three usable current readings.

## Every company
- Jeena Sikho Lifecare Ltd (JSLL) — market value ₹6.5K Cr; latest fundamentals Jun 2026
- Zota Health Care Ltd (ZOTA) — market value ₹3.9K Cr; latest fundamentals Jun 2026

## Source standing of each company

Cross-checked: 2. Unverified: 0. Withheld: 0. Graded companies: 2.

Every company's second-feed figures reconcile against the primary source on overlapping reported periods, so nothing here is unverified or withheld.

## Methodology and freshness

Fundamentals through Jun 2026; prices through 2026-08-14.
Up to 20 quarters per company. Reported history is normalized to Indian rupees crore. Missing values are not interpolated. Derived metrics are calculated only when their inputs are comparable.

## Frequently asked questions

### Is the Ayurvedic sector outperforming NIFTY 500?

Ayurvedic has underperformed NIFTY 500 by 34.3% over 52 weeks and 15.6% over 13 weeks. 0 of 2 covered companies beat NIFTY on Mansfield relative strength, while 1 of 2 beat the sector itself.

### Which Ayurvedic company is largest by revenue?

Jeena Sikho Lifecare Ltd leads with revenue of ₹852 crore, based on 2 of 2 comparable companies through Jun 2026.

### Which Ayurvedic company is growing fastest?

Zota Health Care Ltd has the fastest current revenue growth at 79.1%, across 2 of 2 comparable companies.

### Which Ayurvedic company has the strongest 4-Factor Sector Score?

Jeena Sikho Lifecare Ltd ranks first at 61.9/100 with 84% evidence confidence. The score prioritizes research; it is not a buy recommendation.

### Which Ayurvedic company has the lowest comparable PEG?

Jeena Sikho Lifecare Ltd has the lowest comparable PEG at 4.58, among 1 of 2 companies whose earnings and growth are steady enough for the ratio to mean anything.

### How much history does this Ayurvedic comparison include?

The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

### How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

### Is there a Nifty Ayurvedic index?

NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers Ayurvedic, this page builds its own equal-weight basket of 2 listed Ayurvedic companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.

### Which are the best Ayurvedic stocks in India?

Ranked by this page's four-factor score, Jeena Sikho Lifecare Ltd places first among 2 listed Ayurvedic companies, followed by Zota Health Care Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.

### How many Ayurvedic stocks are listed in India?

This comparison covers 2 listed Ayurvedic companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.

### Which Ayurvedic company is the biggest?

Jeena Sikho Lifecare Ltd is the largest, with trailing-twelve-month revenue of ₹852 crore, ahead of Zota Health Care Ltd at ₹609 crore. That covers 2 of 2 companies with comparable reporting through Jun 2026.

### Which Ayurvedic company has the best profit margins?

Jeena Sikho Lifecare Ltd has the highest operating margin at 41%, from 2 of 2 comparable companies. Jeena Sikho Lifecare Ltd shows the biggest recent improvement, at -4 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

### Which Ayurvedic company makes the most profit?

Jeena Sikho Lifecare Ltd earns the most, at ₹237 crore of trailing-twelve-month net profit, from 2 of 2 comparable companies. Jeena Sikho Lifecare Ltd has the fastest profit growth at the ≥100% scoring cap, though growth off a small or recovering profit base overstates how much has actually changed.

### Which Ayurvedic company earns the highest return on capital?

Jeena Sikho Lifecare Ltd leads on return on capital employed at 64.1%, across 2 of 2 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

### Which Ayurvedic stock is the cheapest?

On PEG — where a LOWER number is cheaper — Jeena Sikho Lifecare Ltd screens cheapest at 4.58×. Only 1 of 2 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.

### Is the Ayurvedic sector beating the market?

Ayurvedic has underperformed NIFTY 500 by 34.3% over the last 52 weeks and 15.6% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 0 of 2 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

### Which Ayurvedic stock has the strongest price momentum?

Zota Health Care Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

### Which Ayurvedic company scores highest for research priority?

Jeena Sikho Lifecare Ltd scores 61.9 out of 100 with 84% evidence confidence, from 28 points on growth and earnings, 20 on capital efficiency, 5 on valuation and 8.9 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

### How many Ayurvedic companies does this comparison cover, and over what period?

It compares 2 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

### What is the total market cap of the Ayurvedic sector?

The 2 Ayurvedic companies on this page carry ₹10,398 crore of combined market value. Jeena Sikho Lifecare Ltd is the largest at ₹6,480 crore, about 62% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-20.

### How is the Ayurvedic sector performing?

0 of the 2 covered Ayurvedic companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 34.3% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-20.

### Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

### Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.